News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
666,459 Results
Type
Article (56470)
Company Profile (224)
Press Release (609760)
Multimedia
Podcasts (193)
Webinars (28)
Section
Business (197127)
Career Advice (2491)
Deals (31540)
Drug Delivery (178)
Drug Development (80519)
Employer Resources (162)
FDA (17097)
Job Trends (13616)
News (308318)
Policy (32579)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (2774)
Academic (1)
Accelerated approval (63)
ADA (49)
Adcomms (43)
Allergies (204)
Alliances (44553)
ALS (250)
Alzheimer's disease (2063)
Antibody-drug conjugate (ADC) (591)
Approvals (17516)
Artificial intelligence (833)
ASCO (337)
Autoimmune disease (406)
Automation (64)
Bankruptcy (331)
Best Places to Work (10541)
BIO (76)
Biologics (1)
BIOSECURE Act (23)
Biosimilars (266)
BioSpace Insights (157)
Biotechnology (150)
Bladder cancer (222)
Brain cancer (84)
Breast cancer (837)
Cancer (6762)
Cardiovascular disease (593)
Career advice (2128)
Career pathing (56)
CAR-T (375)
CDC (77)
Celiac Disease (3)
Cell therapy (1055)
Cervical cancer (60)
Clinical research (70753)
Collaboration (2404)
Commercialization (8)
Company closure (8)
Compensation (1645)
Complete response letters (121)
COVID-19 (2954)
CRISPR (126)
C-suite (1366)
Cystic fibrosis (170)
Data (9092)
Decentralized trials (3)
Denatured (53)
Depression (203)
Dermatology (117)
Diabetes (708)
Diagnostics (6990)
Digital health (61)
Diversity (9)
Diversity, equity & inclusion (43)
Drug discovery (425)
Drug pricing (243)
Drug shortages (35)
Duchenne muscular dystrophy (353)
Earnings (72989)
Editorial (82)
Employer branding (20)
Employer resources (147)
Events (103600)
Executive appointments (1197)
FDA (21455)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (25)
Frontotemporal dementia (37)
Funding (1968)
Gene editing (278)
Generative AI (76)
Gene therapy (865)
GLP-1 (1285)
Government (4829)
Grass and pollen (8)
Guidances (428)
Healthcare (17570)
Hematology (191)
HIV (106)
Huntington's disease (74)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (128)
Immunology and inflammation (380)
Immuno-oncology (114)
Indications (235)
Infectious disease (3368)
Inflammatory bowel disease (249)
Inflation Reduction Act (14)
Influenza (151)
Intellectual property (347)
Interviews (465)
IPO (15546)
IRA (58)
Job creations (3398)
Job search strategy (1723)
JPM (70)
Kidney cancer (26)
Labor market (115)
Layoffs (673)
Leadership (56)
Legal (7452)
Licensing (11)
Liver cancer (111)
Longevity (36)
Lung cancer (914)
Lymphoma (502)
Machine learning (66)
Management (55)
Manufacturing (1221)
Marketing (13)
MASH (234)
Medical affairs (1)
Medical device (12936)
Medtech (13144)
Mergers & acquisitions (17367)
Metabolic disorders (1866)
mRNA (276)
Multiple sclerosis (218)
NASH (24)
Neurodegenerative disease (560)
Neuropsychiatric disorders (136)
Neuroscience (3941)
Neurotech (2)
NextGen: Class of 2026 (5825)
Non-profit (4520)
Now hiring (58)
Obesity (895)
Opinion (340)
Ovarian cancer (248)
Pain (279)
Pancreatic cancer (378)
Parkinson's disease (446)
Partnered (33)
Patents (699)
Patient recruitment (869)
Peanut (70)
People (53502)
Pharmaceutical (50)
Pharmacy benefit managers (36)
Phase 1 (21682)
Phase 2 (31007)
Phase 3 (23805)
Pipeline (11060)
Policy (401)
Postmarket research (2648)
Preclinical (9146)
Press Release (49)
Prostate cancer (364)
Psychedelics (83)
Radiopharmaceuticals (355)
Rare diseases (1405)
Real estate (4988)
Recruiting (68)
Regulatory (26849)
Reports (55)
Research institute (2571)
Resumes & cover letters (413)
Rett syndrome (50)
RNA editing (31)
RSV (100)
Schizophrenia (202)
Series A (343)
Series B (253)
Service/supplier (8)
Sickle cell disease (136)
Special edition (31)
Spinal muscular atrophy (190)
Sponsored (54)
Startups (3389)
State (1)
Stomach cancer (21)
Supply chain (141)
Tariffs (105)
The Weekly (138)
Vaccines (1324)
Venture capital (146)
Weight loss (607)
Women's health (141)
Worklife (25)
Date
Today (125)
Last 7 days (710)
Last 30 days (2588)
Last 365 days (31300)
2026 (19746)
2025 (30752)
2024 (34761)
2023 (39064)
2022 (49955)
2021 (53881)
2020 (51488)
2019 (41942)
2018 (31811)
2017 (31654)
2016 (30539)
2015 (34292)
2014 (27131)
2013 (22345)
2012 (23736)
2011 (24040)
2010 (22266)
Location
Africa (846)
Alabama (87)
Alaska (6)
Arizona (335)
Arkansas (13)
Asia (39667)
Australia (6913)
California (14599)
Canada (3764)
China (1638)
Colorado (594)
Connecticut (663)
Delaware (444)
Europe (95197)
Florida (2212)
Georgia (450)
Hawaii (5)
Idaho (60)
Illinois (1164)
India (105)
Indiana (627)
Iowa (26)
Japan (640)
Kansas (132)
Kentucky (51)
Louisiana (59)
Maine (86)
Maryland (1751)
Massachusetts (10616)
Michigan (343)
Minnesota (783)
Mississippi (6)
Missouri (158)
Montana (29)
Nebraska (28)
Nevada (149)
New Hampshire (74)
New Jersey (3855)
New Mexico (27)
New York (3831)
North Carolina (1856)
North Dakota (9)
Northern California (7498)
Ohio (432)
Oklahoma (26)
Oregon (41)
Pennsylvania (2776)
Puerto Rico (26)
Rhode Island (45)
South America (1187)
South Carolina (90)
South Dakota (2)
Southern California (5759)
Tennessee (228)
Texas (2349)
United States (51293)
Utah (421)
Vermont (1)
Virginia (366)
Washington D.C. (80)
Washington State (1164)
West Virginia (4)
Wisconsin (155)
Wyoming (1)
666,459 Results for "parkinson s disease foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Parkinson’s disease
BioVie shares halve on murky Parkinson’s disease readout
BioVie’s stock fell by nearly 50% as the biotech claimed victory in a mid-stage Parkinson’s disease trial using an alternative endpoint to the primary clinical goal.
August 6, 2026
·
3 min read
·
Gabrielle Masson
Press Releases
Shape Therapeutics Receives Research Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance SHP-201, a One-Time Gene Therapy to Treat Parkinson’s Disease
July 29, 2026
·
3 min read
Parkinson’s disease
Biogen, Denali pull plug on Parkinson’s program after mid-stage flop
Biogen and Denali’s Parkinson’s disease drug failed to significantly slow disease progression in a Phase 2b study, missing both primary and secondary endpoints.
May 22, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Scenic Biotech Joins Michael J. Fox Foundation’s LITE Program to Explore New Disease-Modifying Approach for Parkinson’s Disease
June 11, 2026
·
5 min read
Press Releases
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
June 4, 2026
·
8 min read
Press Releases
Harness Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance Parkinson’s Disease Programme
June 9, 2026
·
3 min read
Press Releases
Thermo Fisher Scientific Collaborates with The Michael J. Fox Foundation to Advance Proteomics-Enabled Parkinson’s Precision Medicine
August 11, 2026
·
4 min read
Press Releases
Lysoway Therapeutics Awarded Grant from The Michael J. Fox Foundation to Advance TMEM175 Agonists for Parkinson’s Disease
June 1, 2026
·
3 min read
Press Releases
BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease
August 6, 2026
·
18 min read
Parkinson’s disease
AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression
In a first for the Parkinson’s field, AC Immune’s immunotherapy has stabilized key biomarkers that suggest an effect on the disease’s course.
December 11, 2025
·
1 min read
·
Annalee Armstrong
1 of 66,646
Next
